StockData
NeoGenomics Inc logo

NeoGenomics Inc (NEO) stock

NEONasdaqServices-Testing LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/3023% below fair value
$15.29+0.04 (+0.26%)

Close on Nov 18, 2026Market cap $1.98BP/E –Yield –

NeoGenomics operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

NeoGenomics's operating cash flow for the twelve months ending Sep 30, 2026 was $4.28M, down 68.7% year over year. For fiscal 2025 it was $5.23M, down 25.5% from the year before. Over ten years it grew -2.0% a year on average. The highest annual figure on record is $44.79M in fiscal 2018.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$5.23M-25.5%
FY2024Dec 31, 2024$7.02M–
FY2023Dec 31, 2023-$1.95M–
FY2022Dec 31, 2022-$65.99M–
FY2021Dec 31, 2021-$26.72M-1930.3%
FY2020Dec 31, 2020$1.46M-93.8%
FY2019Dec 31, 2019$23.37M-47.8%
FY2018Dec 31, 2018$44.79M+148.3%
FY2017Dec 31, 2017$18.04M-16.0%
FY2016Dec 31, 2016$21.48M+235.9%
FY2015Dec 31, 2015$6.39M-32.3%
FY2014Dec 31, 2014$9.45M+324.3%
FY2013Dec 31, 2013$2.23M–
FY2012Dec 31, 2012-$492.00K-813.0%
FY2011Dec 31, 2011$69.00K–
FY2010Dec 31, 2010-$2.05M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$8.89M-200.0%
Q2 FY2026Jun 30, 2026$19.96M-1.8%
Q1 FY2026Mar 31, 2026-$8.14M–
Q4 FY2025Dec 31, 2025$1.34M-86.3%
Q3 FY2025Sep 30, 2025$8.88M-3.9%
Q2 FY2025Jun 30, 2025$20.33M+46.3%
Q1 FY2025Mar 31, 2025-$25.33M–
Q4 FY2024Dec 31, 2024$9.80M-44.9%
Q3 FY2024Sep 30, 2024$9.25M–
Q2 FY2024Jun 30, 2024$13.89M–
Q1 FY2024Mar 31, 2024-$25.92M–
Q4 FY2023Dec 31, 2023$17.78M–
Q3 FY2023Sep 30, 2023-$5.50M–
Q2 FY2023Jun 30, 2023-$1.55M–
Q1 FY2023Mar 31, 2023-$12.69M–
Q4 FY2022Dec 31, 2022-$3.69M–
Q3 FY2022Sep 30, 2022-$16.27M–
Q2 FY2022Jun 30, 2022-$17.00M–
Q1 FY2022Mar 31, 2022-$29.04M-1414.0%
Q4 FY2021Dec 31, 2021-$19.78M-430.4%
Q3 FY2021Sep 30, 2021-$7.77M-1576.6%
Q2 FY2021Jun 30, 2021-$1.39M-173.9%
Q1 FY2021Mar 31, 2021$2.21M–
Q4 FY2020Dec 31, 2020$5.99M+78.2%
Q3 FY2020Sep 30, 2020$526.00K-97.2%
Q2 FY2020Jun 30, 2020$1.88M–
Q1 FY2020Mar 31, 2020-$6.93M-213.7%
Q4 FY2019Dec 31, 2019$3.36M-78.3%
Q3 FY2019Sep 30, 2019$18.63M+122.3%
Q2 FY2019Jun 30, 2019-$4.72M-171.1%
Q1 FY2019Mar 31, 2019$6.10M-57.4%
Q4 FY2018Dec 31, 2018$15.45M+168.3%
Q3 FY2018Sep 30, 2018$8.38M+12.7%
Q2 FY2018Jun 30, 2018$6.64M+1.7%
Q1 FY2018Mar 31, 2018$14.31M–
Q4 FY2017Dec 31, 2017$5.76M–
Q3 FY2017Sep 30, 2017$7.44M–
Q2 FY2017Jun 30, 2017$6.53M–
Q1 FY2017Mar 31, 2017-$1.69M–
Q4 FY2016Dec 31, 2016-$241.00K–

More NeoGenomics figures

See a number that looks wrong?